Surgical Science Sweden AB (publ) (STO:SUS)
Sweden · Delayed Price · Currency is SEK 51.10
-0.70 (-1.35%)
Sep 4, 2026, 5:29 PM CET
STO:SUS Market Cap
STO:SUS has a market cap or net worth of 2.61 billion as of September 4, 2026. Its market cap has decreased by -45.58% in one year.
Market Cap
2.61B
Enterprise Value
1.95B
Revenue
1.02B
Ranking
n/a
PE Ratio
28.08
Stock Price
51.10
ChartMarket Cap Chart
Since June 19, 2017, STO:SUS's market cap has increased from 279.67M to 2.61B, an increase of 832.32%. That is a compound annual growth rate of 27.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 2.61B | 57.23% |
| Dec 30, 2025 | 1.66B | -79.15% |
| Dec 30, 2024 | 7.95B | -14.58% |
| Dec 29, 2023 | 9.31B | 11.30% |
| Dec 30, 2022 | 8.37B | -41.49% |
| Dec 30, 2021 | 14.30B | 343.39% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 158.85B |
| Getinge AB | 66.24B |
| Sectra AB | 56.45B |
| Medicover AB | 36.93B |
| CellaVision AB | 3.93B |
| Egetis Therapeutics AB | 3.67B |
| Humana AB | 3.37B |
| Vicore Pharma Holding AB | 3.01B |